Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
Background Medications used to treat inflammatory bowel disease (IBD) have significantly
improved patient outcomes and delayed time to surgery. However, some of these therapies …
improved patient outcomes and delayed time to surgery. However, some of these therapies …
Perioperative care of patients with inflammatory bowel disease: focus on nutritional support
PL Stoner, A Kamel, F Ayoub, S Tan… - Gastroenterology …, 2018 - Wiley Online Library
Patients with inflammatory bowel disease (IBD) commonly require surgery despite the
availability of an increasingly large repertoire of powerful immunosuppressive medications …
availability of an increasingly large repertoire of powerful immunosuppressive medications …
[HTML][HTML] Surgical morbidity is acceptable following a one or two stage mesentery-including surgery for Crohn's disease and comparable to mesentery-sparing surgery
CA Fleming, HM Mohan, M Kiernan… - Mesentery and …, 2023 - map.amegroups.org
Background: It has recently been suggested that mesenteric-including (MI) resection for
Crohn's disease (CD) is associated with reduced surgical recurrence. Whilst there is a …
Crohn's disease (CD) is associated with reduced surgical recurrence. Whilst there is a …
Post-Operative Outcomes in Patients Undergoing Abdominal Surgery for Crohn's Disease Treated with Pre-Operative Ustekinumab: A Systematic Review and Meta …
N Gupta, E Bellaguarda, E Wafford… - World Journal of …, 2022 - journals.lww.com
Background: Ustekinumab is a monoclonal antibody targeting interleukins 12 and 23 to treat
Crohn's disease. Effects on surgical complications and outcomes are not well understood …
Crohn's disease. Effects on surgical complications and outcomes are not well understood …